Gene · 5106
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Food Polyphenols as Preventive Medicine. | Antioxidants (Basel) | 2023 | 38136222 | PubTator, text mining | PubMed |
| Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence. | Nat Commun | 2023 | 38114497 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Phylogenetic Analysis Provides Insight Into the Molecular Evolution of Nociception and Pain-Related Proteins. | Evol Bioinform Online | 2023 | 38107163 | PubTator, text mining | PubMed |
| Notoginsenoside-R1 ameliorates palmitic acid-induced insulin resistance and oxidative stress in HUVEC via Nrf2/ARE pathway. | Food Sci Nutr | 2023 | 38107110 | PubTator, text mining | PubMed |
| Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway. | BMC Complement Med Ther | 2023 | 38102588 | PubTator, text mining | PubMed |
| SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts. | Stem Cell Res Ther | 2023 | 38087340 | PubTator, text mining | PubMed |
| Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2023 | 38083797 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion. | World J Diabetes | 2023 | 38077805 | PubTator, text mining | PubMed |
| Targeting NR1D1 in organ injury: challenges and prospects. | Mil Med Res | 2023 | 38072952 | PubTator, text mining | PubMed |
| Biochemical and Structural Diversification of C4 Photosynthesis in Tribe Zoysieae (Poaceae). | Plants (Basel) | 2023 | 38068683 | PubTator, text mining | PubMed |
| Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. | Front Cell Dev Biol | 2023 | 38054182 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. | Front Oncol | 2023 | 38053661 | PubTator, text mining | PubMed |
| Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes. | Diabetol Metab Syndr | 2023 | 38044448 | PubTator, text mining | PubMed |
| Methylmalonyl Coenzyme A (CoA) Epimerase Deficiency, an Ultra-Rare Cause of Isolated Methylmalonic Aciduria With Predominant Neurological Features. | Cureus | 2023 | 38034150 | PubTator, text mining | PubMed |
| Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway. | Int J Immunopathol Pharmacol | 2023 | 38031977 | PubTator, text mining | PubMed |
| Integrated investigation and discovery of therapeutic targets for 3-hydroxybakuchiol against diabetes based on molecular docking studies and cell experiments. | BMC Complement Med Ther | 2023 | 38031191 | PubTator, text mining | PubMed |
| Use of Monoterpenes as Potential Therapeutics in Diabetes Mellitus: A Prospective Review. | Adv Pharmacol Pharm Sci | 2023 | 38029230 | PubTator, text mining | PubMed |
| The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. | Front Genet | 2023 | 38028615 | PubTator, text mining | PubMed |
| Breast cancer therapies reduce risk of Alzheimer's disease and promote estrogenic pathways and action in brain. | iScience | 2023 | 38026173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5106/papers?page=11